Sign inGet started

Fruchtman Steven M

Insider CIK 1631251 · ONTX President, Chief Medical Off, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ONTX Onconova Therapeutics, Inc F Tax w/h2024-03-142024-03-158,727$0.90 $7.9K74,792SEC↗
ONTX Onconova Therapeutics, Inc M Exercise deriv2024-03-132024-03-1523,111— $046,222SEC↗
ONTX Onconova Therapeutics, Inc M Exercise2024-03-132024-03-1523,111— $083,519SEC↗
ONTX Onconova Therapeutics, Inc M Exercise deriv2024-02-072024-02-0921,320— $021,320SEC↗
ONTX Onconova Therapeutics, Inc M Exercise2024-02-072024-02-0921,320— $069,620SEC↗
ONTX Onconova Therapeutics, Inc F Tax w/h2024-02-072024-02-099,212$0.67 $6.2K60,408SEC↗
ONTX Onconova Therapeutics, Inc F Tax w/h2023-08-032023-08-044,744$1.01 $4.8K48,300SEC↗
ONTX Onconova Therapeutics, Inc M Exercise deriv2023-08-022023-08-0412,567— $012,567SEC↗
ONTX Onconova Therapeutics, Inc M Exercise2023-08-022023-08-0412,567— $053,044SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2023-03-132023-03-14207,000— $0207,000SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2023-03-132023-03-1469,333— $069,333SEC↗
ONTX Onconova Therapeutics, Inc M Exercise deriv2023-02-072023-02-0821,320— $042,640SEC↗
ONTX Onconova Therapeutics, Inc F Tax w/h2023-02-072023-02-086,977$1.36 $9.5K40,477SEC↗
ONTX Onconova Therapeutics, Inc M Exercise2023-02-072023-02-0821,320— $047,454SEC↗
ONTX Onconova Therapeutics, Inc F Tax w/h2022-08-032022-08-044,562$1.32 $6.0K26,134SEC↗
ONTX Onconova Therapeutics, Inc M Exercise deriv2022-08-022022-08-0412,566— $025,134SEC↗
ONTX Onconova Therapeutics, Inc M Exercise2022-08-022022-08-0412,566— $030,696SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2022-02-072022-02-09191,880— $0191,880SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2022-02-072022-02-0963,960— $063,960SEC↗
ONTX Onconova Therapeutics, Inc P Buy2021-09-282021-09-282,381$4.20 $10.0K18,130SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2021-08-022021-08-0437,700— $037,700SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2021-08-022021-08-04113,000— $0113,000SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2021-02-172021-02-19706,000— $0706,000SEC↗
ONTX Onconova Therapeutics, Inc P Buy2021-02-162021-02-1720,000$1.00 $20.0K236,226SEC↗
ONTX Onconova Therapeutics, Inc P Buy2020-11-252020-11-3040,000$0.26 $10.4K216,226SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2020-07-092020-07-101,273,800— $01,273,800SEC↗
ONTX Onconova Therapeutics, Inc P Buy2020-05-192020-05-2026,800$0.37 $9.9K176,226SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2019-12-202019-12-26200,000— $0200,000SEC↗
ONTX Onconova Therapeutics, Inc P Buy deriv2019-11-252019-11-26149,000— $0149,000SEC↗
ONTX Onconova Therapeutics, Inc P Buy2019-11-252019-11-26149,000$0.20 $29.8K149,426SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2018-07-262018-07-30400,000— $0400,000SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2018-01-032018-01-0543,627— $043,627SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2017-01-172017-01-1926,401— $026,401SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2016-12-152016-12-197,599— $07,599SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2016-09-012016-09-0125,000— $025,000SEC↗
ONTX Onconova Therapeutics, Inc X Exercise deriv2016-07-292016-08-104,706— $04,706SEC↗
ONTX Onconova Therapeutics, Inc X Exercise2016-07-292016-08-106,276$4.10 $25.7K6,376SEC↗
ONTX Onconova Therapeutics, Inc X Exercise deriv2016-07-262016-08-10150— $00SEC↗
ONTX Onconova Therapeutics, Inc M Exercise deriv2016-06-242016-06-30100— $012,411SEC↗
ONTX Onconova Therapeutics, Inc M Exercise2016-06-242016-06-30100$6.50 $650100SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2016-01-262016-01-28125,107— $0125,107SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2015-09-252015-10-0140,000— $040,000SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2015-04-202015-04-2235,000— $035,000SEC↗